Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-World Study Evaluating the Effectiveness and Safety of Immune Checkpoint Inhibitors and Chemotherapy for Advanced Esophageal Cancer

NCT04822103 is registered in ClinicalTrials.gov with Guangdong Provincial People's Hospital as lead sponsor.

NCT NCT04822103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04822103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-World Study Evaluating the Effectiveness and Safety of Immune Checkpoint Inhibitors and Chemotherapy for Advanced Esophageal Cancer
Lead sponsor
Guangdong Provincial People's Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2021
Completion date
October 31, 2021
Enrollment
155 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer